Twenty-four hour profile of the anti-hypertensive action of isradipine in essential hypertension
CJS Low, SG Foy, H Chaudhary, IG Crozier… - Blood …, 1993 - Taylor & Francis
Isradipine, 2.5 mg twice daily and placebo were administered for 4 weeks to 11 untreated
essential hypertensives in a double-blind, random order, crossover study. At the end of each …
essential hypertensives in a double-blind, random order, crossover study. At the end of each …
[PDF][PDF] Twenty-Four Hour Profile of the Anti-hypertensive Action of Isradipine in Essential Hypertension
CJS Low, SG Foy, H Chaudhary, IG Crozier… - BLOOD …, 1993 - researchgate.net
Isradipine is a dihydropyridine calcium channel antagonist with high selectivity for vascular
smooth muscle; especially coronary, cerebral and skeletal beds (1). Its prolonged …
smooth muscle; especially coronary, cerebral and skeletal beds (1). Its prolonged …
Twenty-four hour profile of the anti-hypertensive action of isradipine in essential hypertension.
CJ Low, SG Foy, H Chaudhary, IG Crozier… - Blood …, 1993 - europepmc.org
Isradipine, 2.5 mg twice daily and placebo were administered for 4 weeks to 11 untreated
essential hypertensives in a double-blind, random order, crossover study. At the end of each …
essential hypertensives in a double-blind, random order, crossover study. At the end of each …
Twenty-four hour profile of the anti-hypertensive action of isradipine in essential hypertension
CJ Low, SG Foy, H Chaudhary, IG Crozier… - Blood …, 1993 - pubmed.ncbi.nlm.nih.gov
Isradipine, 2.5 mg twice daily and placebo were administered for 4 weeks to 11 untreated
essential hypertensives in a double-blind, random order, crossover study. At the end of each …
essential hypertensives in a double-blind, random order, crossover study. At the end of each …